Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy

Pediatric Cardiology

Volumn 29, Issue 2, 2008, Pages 343-351

  Rhodes, J ^a   Margossian, R ^a   Darras, B T ^a   Colan, S D ^a   Jenkins, K J ^a   Geva, T ^a   Powell, A J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cardiac magnetic resonance imaging; Carvedilol; Dilated cardiomyopathy; Muscular dystrophy; Ventricular function

Indexed keywords

CARVEDILOL; DIGOXIN;

ADOLESCENT; ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; BLOOD PRESSURE; CARDIAC PATIENT; CHILD CARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFORMANCE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; LUNG FUNCTION TEST; MUSCULAR DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; QUESTIONNAIRE; TREATMENT RESPONSE;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; CARBAZOLES; CARDIOMYOPATHY, DILATED; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ELECTROCARDIOGRAPHY, AMBULATORY; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUSCULAR DYSTROPHIES; MYOCARDIAL CONTRACTION; PROPANOLAMINES; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 40949086482     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-007-9113-z     Document Type: Article

References (26)

1. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU (2003) Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 17:323-329
2. Bruns LA, Chrisant MK, Lamour JM, Shaddy RE, Pahl E, Blume ED, Hallowell S, Addonizio L, Canter CE (2001) Carvedilol as therapy in pediatric heart failure: an intial multicenter experience. J Pediatr 138:511
3. Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12:329-343
4. Duboc D, Meune C, Lerebours G, Deveaux JY, Vaksmann G, Becane HM (2005) Effect of peridopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 45:855-857
5. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Lang C, Kubo SH, Rudin-Toretsky E, Salim Y (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 82:1724-1729
6. Frishman WH (1998) Carvedilol N Engl J Med 339:1759-1765
7. Grothues F, Smith GC, Moon JCC, Bellenger NG, Collins P, Klein HU, Pennell DJ (2002) Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90:29-34
8. Hiramatsu S, Maekawa K, Hioka T: Female carrier of Duchenne muscular dystrophy presenting with secondary dilated cardiomyopathy: a case report. J Cardiol 200 38(Suppl):35-40
9. Ishikawa K (1997) Cardiac involvement in progressive muscular dystrophy of the Duchenne type. Jpn Heart J 38:163-179
10. Ishikawa Y, Bach JR, Minami R (1999) Cardioprotection for Duchenne's muscular dystrophy. Am Heart J 137:895-902
11. Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, O'Brian Smith E, Towbin JA (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799-2804
12. Kajimoto K, Ishigake K, Okumura K, Tomimatsu H, Nakazawa M, Saito K, Osawa M, Nakanishi T (2006) Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circ J 70:991-994
13. Kantor HL, Krishnan SC (1995) Cardiologic problems in patients with neurologic disease. Cardiol Clin 13:179-208
14. Kennedy JD, Staples A.J., Brooks PD, Parsons DW, Sutherland AD, Martin AJ, Stern LM, Foster BK (1995) Effect of spinal surgery on lung function in Duchenne muscular dystrophy. Thorax 50:1173-1178
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pelikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, St John Sutton M, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group. J Am Soc Echocardiogr 18:1440-1463
16. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr (1999) Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1:7-21
17. Ommen SR, Nishimura SA, Applerton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788-1794
18. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P (2001) Effect of carvedilol on survival in severe heart failure. N Engl J Med 344:1651-1658
19. Parthenakis FI, Kanakaraki MK, Kanoupakis EM, Skalidis EI, Diakakis GF, Filippou OK, Vardas PE (2002) Value of Doppler index combining systolic and diastolic myocardial performance in predicting cardiopulmonary exercise capacity in patients with congestive heart failure: effects of dobutamine. Chest 121:1935-1941
20. Rhodes J, Udelson JE, Marx GR, Schmidt CH, Konstam MA, Hijazi ZM, Bova SA, Fulton DR (1993) A new noninvasive method for the estimation of peak dP/dt. Circulation 88:2693-2699
21. Saito T, Matsumura T, Miyai I, Nozaki S, Shinno S (2001) Carvedilol effectiveness for left ventricular-insufficient patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku 41:691-694
22. Schleman KA, Lindenfeld JA, Lowes BD, Bristow MR, Ferguson D, Wolfel EE, Abraham WT, Zisman LS (2001) Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis. J Card Fail 7:4-12
23. Shaddy RE, Curtin EL, Sower B, Tani LY, Burr J, LaSalle B, Boucek MM, Mahoney L, Hsu DT, Pahl E, Burch GH, Schlenker-Herceg R (2002) The pediatric randomized carvedilol trial in children with chronic heart failure: rationale and design. Am Heart J, 144:383-389
24. Shaddy RE, Tani LY, Gidding SS, Pahl E, Orsmond GS, Gilbert EM, Lemes V (1999) Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 18:269-274
25. Steare SE, Dubowitz V, Benatar A (1992) Subclincial cardiomyopathy in Becker muscular dystrophy. Br Heart J 68:304-308
26. Tei C (1995) New noninvasive index for combined systolic and diastolic ventricular function. J Cardiol 26:135-136